Prospective observational study on the impact of vaccination against COVID19 in patients with cancer

Prospective observational study on the impact of vaccination against COVID19 in patients with cancer - Prospective observational study on the impact of vaccination against COVID19 in patients with cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049403

Enrollment

1000

Registered

2022-11-02

Start date

2021-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Age 16 years or older at the time of consent 2) Patients with cancer at the National Cancer Center Hospital (regardless of cancer type or stage) 3) Have blood samples taken at this hospital at least once every three months. 4) Adults whose written consent for this study has been obtained by the patient, or minors whose written consent for this study has been obtained by the patient 5) Scheduled to receive COVID-19 vaccine or within approximately 6 months of the second (or last) dose of the vaccine

Exclusion criteria

Exclusion criteria: Subjects who are determined by the principal investigator or physician in charge to be inappropriate as subjects for this study

Design outcomes

Primary

Measure	Time frame
SARS-CoV-2 antibody positivity after 2 doses of vaccine	—

Countries

Japan

Contacts

Public ContactYuki Katsuya

National Cancer Center Hospital Department of experimental development

ykatsuya@ncc.go.jp03-3542-2511

Outcome results